FDA Approves Unknown Drug — MANKIND PHARMA

# FDA Approves Mankind Pharma Generic Drug Application Mankind Pharma has received FDA approval for its abbreviated new drug application (ANDA220398), expanding the company's generic pharmaceutical portfolio and positioning it to capture additional market share in the competitive generics sector. The approval demonstrates Mankind Pharma's continued investment in its U.S. regulatory strategy and could provide the company with near-term revenue opportunities as it launches this generic product into an established market.